Carol S. Connor

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

Priyanka Sharma, Jennifer R. Klemp, Bruce F. Kimler et al. · Breast Cancer Research and Treatment · 2014 · 215 citations · Full text

Life Sciences, Genetics, Oncology +14

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz et al. · Clinical Cancer Research · 2016 · 138 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence <i>in‐situ</i> hybridization in the evaluation of HER‐2/<i>neu</i> expression in primary breast carcinoma

Ossama Tawfik, B. F. Kimler, M. Davis et al. · Histopathology · 2005 · 72 citations

Medicine, Cancer Biology, Oncology +17

A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens

Carol S. Connor, Ossama Tawfik, Alina J Joyce et al. · The American Journal of Surgery · 2002 · 63 citations

Medicine, Oncology, Pathology +16

Significance of tumor spread in adenocarcinoma of the ampulla of vater

Romano Delcore, Carol S. Connor, James H. Thomas et al. · The American Journal of Surgery · 1989 · 46 citations

Medicine, Oncology, Surgery +12